229 related articles for article (PubMed ID: 11149026)
21. Hepatitis B antigen, alpha1 fetoprotein and liver disease in the eastern highlands of Papua New Guinea.
Clarke CW; Woodfield G
Trop Geogr Med; 1975 Mar; 27(1):52-8. PubMed ID: 49112
[TBL] [Abstract][Full Text] [Related]
22. [Serum concentrations of tissue polypeptide antigen and alpha 1-fetoprotein in patients with primary liver cancer, liver metastasis and liver cirrhosis].
Polterauer P; Legenstein E; Müller M
Wien Klin Wochenschr; 1985 Apr; 97(9):417-20. PubMed ID: 2408389
[TBL] [Abstract][Full Text] [Related]
23. [Diagnosis, treatment and prognosis of single-nodular minute hepatocellular carcinoma].
Zhou X
Zhonghua Yi Xue Za Zhi; 1990 Jun; 70(6):330-3, 24. PubMed ID: 1698522
[TBL] [Abstract][Full Text] [Related]
24. Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma.
Cai X; Peng S; Xiao X; Huang Z; Zhang P
Sci Rep; 2024 May; 14(1):10996. PubMed ID: 38744926
[TBL] [Abstract][Full Text] [Related]
25. Screening studies and markers.
Jones DB; Koorey DJ
Gastroenterol Clin North Am; 1987 Dec; 16(4):563-73. PubMed ID: 2450066
[TBL] [Abstract][Full Text] [Related]
26. Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review.
Wu JT
Ann Clin Lab Sci; 1990; 20(2):98-105. PubMed ID: 1691611
[TBL] [Abstract][Full Text] [Related]
27. Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis.
Gopal P; Yopp AC; Waljee AK; Chiang J; Nehra M; Kandunoori P; Singal AG
Clin Gastroenterol Hepatol; 2014 May; 12(5):870-7. PubMed ID: 24095974
[TBL] [Abstract][Full Text] [Related]
28. Role of serum alpha-fetoprotein in pre- and post-orthotopic liver transplantation (OLT) for malignant disease.
Andorno E; Salizzoni M; Schieroni R; De Hemptinne B
J Nucl Med Allied Sci; 1989; 33(3 Suppl):132-4. PubMed ID: 2480413
[TBL] [Abstract][Full Text] [Related]
29. Combination of an Autoantibody Panel and Alpha-Fetoprotein for Early Detection of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Shen Y; Chen J; Wu J; Li T; Yi C; Wang K; Wang P; Sun C; Ye H
Cancer Prev Res (Phila); 2024 May; 17(5):227-235. PubMed ID: 38489403
[TBL] [Abstract][Full Text] [Related]
30. [Early diagnosis of hepatocarcinoma: criteria for the performance of screening in patients with liver cirrhosis].
Cristani A; Cioni G; Vignoli A; Zerbinati F; Ventura P; Tincani E; De Santis M; Ventura E
Recenti Prog Med; 1991; 82(7-8):394-6. PubMed ID: 1658881
[TBL] [Abstract][Full Text] [Related]
31. Etiology of human liver cancer: controlled prospective study in liver cirrhosis.
Lehmann FG; Wegener T
J Toxicol Environ Health; 1979; 5(2-3):281-99. PubMed ID: 89198
[TBL] [Abstract][Full Text] [Related]
32. Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis.
Alpert E; Feller ER
Gastroenterology; 1978 May; 74(5 Pt 1):856-8. PubMed ID: 76587
[TBL] [Abstract][Full Text] [Related]
33. [Severely increased alpha fetoprotein and associated diseases].
Ganz M; Joller-Jemelka HI; Grob PJ
Schweiz Med Wochenschr; 1979 Sep; 109(36):1314-22. PubMed ID: 92051
[TBL] [Abstract][Full Text] [Related]
34. Serum β-klotho is a potential biomarker for the progression of hepatitis B virus-related liver diseases.
Miao X; Peng C; Yan F; Guo X; Xia L; Song Q; An X; Wu G
J Infect Dev Ctries; 2024 Apr; 18(4):618-626. PubMed ID: 38728647
[TBL] [Abstract][Full Text] [Related]
35. Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response.
Chida T; Ohta K; Noritake H; Matsushita M; Murohisa G; Kageyama F; Sasada Y; Oyaizu T; Tsugiki M; Tamakoshi K; Nakajima T; Suda T; Kawata K
Sci Rep; 2024 May; 14(1):10864. PubMed ID: 38740815
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of serum and urinary neopterin levels in patients with various liver diseases.
Daito K; Suou T; Kawasaki H
Am J Gastroenterol; 1992 Apr; 87(4):471-6. PubMed ID: 1313206
[TBL] [Abstract][Full Text] [Related]
37. [Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin].
Pol S; Nalpas B; Bezeaud A; Bréchot C; Berthelot P
Gastroenterol Clin Biol; 1986 Feb; 10(2):112-6. PubMed ID: 2422087
[TBL] [Abstract][Full Text] [Related]
38. Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.
Kashala LO; Kalengayi MM; Essex M
Cancer Invest; 1992; 10(6):513-22. PubMed ID: 1384940
[TBL] [Abstract][Full Text] [Related]
39. [Alpha1-fetoprotein: physiology, pathology and diagnosis especially in childhood (author's transl)].
Knöpfle G; Becker M; Rotthauwe HW
Klin Padiatr; 1977 Jul; 189(4):207-26. PubMed ID: 70546
[TBL] [Abstract][Full Text] [Related]
40. Relationship of serum alpha-fetoprotein to the severity and duration of illness in patients with viral hepatitis.
Bloomer JR; Waldmann TA; McIntire R; Klatskin G
Gastroenterology; 1975 Feb; 68(2):342-50. PubMed ID: 163780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
